Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
03 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250703172615/en/Viridian-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4
05 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250605057671/en/Viridian-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
30 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250530073339/en/Viridian-Therapeutics-to-Participate-in-Upcoming-June-Investor-Conferences
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520329293/en/Viridian-Therapeutics-Announces-Positive-Long-Term-Durability-Data-from-the-Veligrotug-Phase-3-THRIVE-Clinical-Trial-in-Patients-with-Active-Thyroid-Eye-Disease-TED
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507164030/en/Viridian-Therapeutics-Receives-FDA-Breakthrough-Therapy-Designation-for-Veligrotug-for-the-Treatment-of-Thyroid-Eye-Disease-TED
06 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250506203388/en/Viridian-Therapeutics-Highlights-Recent-Progress-and-Reports-First-Quarter-2025-Financial-Results
ABOUT THIS PAGE